Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
NCT ID: NCT00998374
Last Updated: 2014-04-21
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
62 participants
OBSERVATIONAL
2009-09-30
2013-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Weight Loss-Independent Metabolic Effects of Roux-En-Y Gastric Bypass in Diabetes
NCT02207777
Changes in Glucose Metabolism After Roux-en-Y Gastric Bypass
NCT01993511
Gut Hormones After Roux-en-Y Gastric Bypass (RYGBP) Plus Gastric Fundus Resection
NCT01341028
Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1
NCT01930448
Gut Microbiota Post Roux-en-Y Gastric Bypass Surgery
NCT02654496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of this clinical trial is to determine whether an intact pylorus prevents reactive hypoglycemia following challenge with liquid glucose preparation and/or solid load made of refined flour product that is a simple carbohydrate.
Clinical Trial Design:
This is a prospective, non-randomized, clinical trial.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pyloric-sparing vs. non-pyloric sparing
Pyloric: SG \& DS Non-pyloric: RYGB
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient has a BMI \> 35;
* Patient meets standards for bariatric surgery;
Exclusion Criteria
* The patient has been diagnosed with a severe eating disorder;
* The patient is currently pregnant (pregnancy test required for confirmation for those of child bearing years);
* The patient is unable to comply with the study requirements, follow-up schedule, or to give valid informed consent
19 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medtronic - MITG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mitchell Roslin, MD
Role: PRINCIPAL_INVESTIGATOR
Lenox Hill Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lenox Hill Hospital 186 E76th Street, 1st Floor
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AS08018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.